The top public health officials during Trump's first term praised mRNA vaccines. In the second term, officials seem to be ...

They’re turning their backs on a technology thought to have saved millions of lives—with the potential to save many more.

The NIH’s Jay Bhattacharya tried his best pitch to explain the Trump administration’s shift away from mRNA vaccine research.

The Trump administration’s decision to halt nearly $500 million for mRNA vaccine research has made investors more hesitant to ...

The Department of Health and Human Services’ mRNA pullback only applies to their use in upper respiratory disease, according ...

WASHINGTON -- So-called mRNA vaccines saved millions of lives during the COVID-19 pandemic — and now scientists are using ...

US Government cuts to mRNA vaccine research could set technological advances, reduce access to therapies, and raise their ...

RNA vaccines were a game-changer in the fight against COVID-19 — but now, their future could be shifting. The U.S. Department ...

When U.S. Health and Human Services Secretary Robert F. Kennedy Jr. announced the cancellation of $500 million in funding for the development of mRNA vaccines, the national headlines focused on ...

mRNA vaccines are a very new technology, and had a long road to being developed. Indeed, it has been thirty years since the first paper came out that proposed using mRNA for vaccines.

Director Jay Bhattacharya claims the federal government recently canceled millions of dollars’ worth of mRNA research ...